Cite

HARVARD Citation

    Wang, A. et al. (2021). Programmed Cell Death Protein Ligand 2 Is a Potential Biomarker That Predicts the Efficacy of Immunotherapy. Disease markers. p. . [Online]. 
  
Back to record